Taxotere® (T) and doxorubicin (D) combination: a phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

Autor:	J.M. Reyes, C. Vallejos, P. Gavilanes, L. Orlandi, H. Carranza, A. Majlis, E. Salas, P. Nunez, B. Boussard, M. Fodor
Rok vydání:	1999
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry medicine.disease Metastatic breast cancer First line treatment Internal medicine South american medicine Doxorubicin business medicine.drug
Zdroj:	European Journal of Cancer. 35:S329
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(99)81740-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::58a0f919e324355a69cb48cf22515425 https://doi.org/10.1016/s0959-8049(99)81740-7 Zobrazit plný text záznamu Full Text from ScienceDirect